Luminex (LMNX) Receives Daily Media Impact Rating of 0.44

Luminex (LMNX) Receives Daily Media Impact Rating of 0.44

These are some of the headlines that may have effected AlphaOne Sentiment Analysis’s scoring:

News articles about Luminex (NASDAQ:LMNX) have trended positive on Tuesday, according to Alpha One. The research group, a service of Accern, rates the sentiment of media coverage by analyzing more than 20 million blog and news sources in real-time. Alpha One ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Luminex earned a coverage optimism score of 0.44 on Alpha One’s scale. Alpha One also assigned media coverage about the medical instruments supplier an impact score of 75 out of 100, meaning that recent media coverage is likely to have an impact on the stock’s share price in the next few days.

A number of analysts have recently commented on the company. Piper Jaffray Companies cut their price target on Luminex from $20.00 to $19.00 and set a “neutral” rating on the stock in a research note on Tuesday, February 7th. ValuEngine raised Luminex from a “sell” rating to a “hold” rating in a research note on Thursday, May 11th. Zacks Investment Research raised Luminex from a “sell” rating to a “hold” rating in a research note on Tuesday, April 4th. Jefferies Group LLC lifted their price target on Luminex from $20.00 to $21.00 and gave the company a “hold” rating in a research note on Tuesday, May 2nd. Finally, William Blair reissued a “market perform” rating on shares of Luminex in a research note on Tuesday, February 7th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, one has issued a buy rating and one has given a strong buy rating to the stock. Luminex presently has an average rating of “Hold” and a consensus price target of $21.83.

Luminex (LMNX) opened at 20.38 on Tuesday. The company has a 50 day moving average price of $19.74 and a 200-day moving average price of $19.57. Luminex has a 1-year low of $17.64 and a 1-year high of $23.75. The firm has a market capitalization of $895.21 million, a price-to-earnings ratio of 63.29 and a beta of 0.59.

Luminex (NASDAQ:LMNX) last announced its quarterly earnings data on Monday, May 1st. The medical instruments supplier reported $0.28 EPS for the quarter, beating the consensus estimate of $0.16 by $0.12. The firm had revenue of $77.80 million for the quarter, compared to analyst estimates of $74.25 million. Luminex had a return on equity of 5.53% and a net margin of 5.10%. The company’s revenue was up 23.5% on a year-over-year basis. During the same period in the prior year, the company earned $0.29 EPS. On average, analysts forecast that Luminex will post $0.52 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 14th. Stockholders of record on Friday, June 23rd will be given a dividend of $0.06 per share. The ex-dividend date is Wednesday, June 21st. This represents a $0.24 annualized dividend and a dividend yield of 1.18%.

In related news, Director G Walter Loewenbaum II sold 25,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 23rd. The stock was sold at an average price of $20.23, for a total transaction of $505,750.00. Following the transaction, the director now directly owns 738,896 shares in the company, valued at approximately $14,947,866.08. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. 6.90% of the stock is currently owned by corporate insiders.

About Luminex

Luminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company’s products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “NASDAQ:LMNX”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Related posts

Leave a Comment